<DOC>
	<DOCNO>NCT01441622</DOCNO>
	<brief_summary>Continuous Positive Airway Pressure ( CPAP ) standard treatment patient Obstructive Sleep Apnea Syndrome ( OSAS ) . The goal study evaluate CPAP treatment duration record AL539 attend in-hospital polysomnography patient Obstructive Sleep Apnea Syndrome .</brief_summary>
	<brief_title>Evaluation New Medical Device AL539 Patients With Obstructive Apneas Sleep Syndrome</brief_title>
	<detailed_description>Patients patient sleep apnea predominantly obstructive , CPAP least 2 month , require in-hospital night polygraphic record control . The medical device develop determine : - duration use CPAP patient , - persistence respiratory abnormality treatment . These two parameter used ensure treatment do correctly . The use AL539 expect improve home-monitoring ventilation CPAP .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Sleep apnea predominantly obstructive CPAP least 2 month require inhospital night polygraphic record Written inform consent form Able read write French Ventilator two level pressure CPAP breathing circuit noncompatible AL539 Chronic respiratory disease Psychotropic treatment may influence respiratory parameter Acute rhinitis acute nasopharyngitis Moderate severe chronic heart failure CHEYNESTOKES respiration Body mass index ( BMI ) &gt; 40 Pregnant woman woman childbearing potential positive urinary pregnancy test Uncontrolled progressive disease Psychiatric disorder regular user drug Participation interventional clinical trial within 30 day prior selection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Continuous Positive Airway Pressure ( CPAP )</keyword>
	<keyword>AL539</keyword>
	<keyword>Home-monitoring</keyword>
</DOC>